Olfactory neuroblastoma: long-term clinical outcome at a single institute between 1979 and 2003.

Kazunari Nakao, Kenta Watanabe, Yoshinori Fujishiro, Yasuhiro Ebihara, Takahiro Asakage, Akiteru Goto, Nobutaka Kawahara
{"title":"Olfactory neuroblastoma: long-term clinical outcome at a single institute between 1979 and 2003.","authors":"Kazunari Nakao,&nbsp;Kenta Watanabe,&nbsp;Yoshinori Fujishiro,&nbsp;Yasuhiro Ebihara,&nbsp;Takahiro Asakage,&nbsp;Akiteru Goto,&nbsp;Nobutaka Kawahara","doi":"10.1080/03655230701599982","DOIUrl":null,"url":null,"abstract":"<p><strong>Conclusions: </strong>The progression of olfactory neuroblastoma showed a biphasic pattern. As well as Hyams' histopathological grading and neck metastasis at presentation, early phase recurrence should be regarded as an important prognosticator. A high local failure rate suggests that craniofacial resection followed by postoperative radiotherapy should still be the standard treatment for olfactory neuroblastoma.</p><p><strong>Objective: </strong>The aim of this study was to evaluate factors associated with survival and local control of olfactory neuroblastoma in the long run and to estimate treatment strategies.</p><p><strong>Patients and methods: </strong>Twelve patients (seven men and five women) who had undergone initial curative treatment for olfactory neuroblastoma were retrospectively analyzed.</p><p><strong>Results: </strong>Cause-specific 10-year survival was 64.8%, while disease-free 10-year survival remained 28.6%. Local failure was found in half of the patients. All of the three patients who did not receive radiotherapy developed local failure. A biphasic pattern of recurrence was observed. The early phase recurrence group showed a significantly poorer survival than the late phase recurrence group. Hyams' histopathological grading and neck metastasis at presentation were also correlated with survival.</p>","PeriodicalId":7027,"journal":{"name":"Acta oto-laryngologica. Supplementum","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/03655230701599982","citationCount":"17","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta oto-laryngologica. Supplementum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/03655230701599982","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 17

Abstract

Conclusions: The progression of olfactory neuroblastoma showed a biphasic pattern. As well as Hyams' histopathological grading and neck metastasis at presentation, early phase recurrence should be regarded as an important prognosticator. A high local failure rate suggests that craniofacial resection followed by postoperative radiotherapy should still be the standard treatment for olfactory neuroblastoma.

Objective: The aim of this study was to evaluate factors associated with survival and local control of olfactory neuroblastoma in the long run and to estimate treatment strategies.

Patients and methods: Twelve patients (seven men and five women) who had undergone initial curative treatment for olfactory neuroblastoma were retrospectively analyzed.

Results: Cause-specific 10-year survival was 64.8%, while disease-free 10-year survival remained 28.6%. Local failure was found in half of the patients. All of the three patients who did not receive radiotherapy developed local failure. A biphasic pattern of recurrence was observed. The early phase recurrence group showed a significantly poorer survival than the late phase recurrence group. Hyams' histopathological grading and neck metastasis at presentation were also correlated with survival.

嗅觉神经母细胞瘤:1979年至2003年间单个研究所的长期临床结果。
结论:嗅神经母细胞瘤的发展呈双期模式。除了Hyams的组织病理学分级和颈部转移外,早期复发应被视为重要的预后指标。高局部失败率提示颅面切除术后放疗仍应是嗅觉神经母细胞瘤的标准治疗方法。目的:本研究的目的是评估嗅觉神经母细胞瘤长期生存和局部控制的相关因素,并评估治疗策略。患者和方法:回顾性分析12例(男7例,女5例)接受嗅觉母神经细胞瘤初步治愈治疗的患者。结果:病因特异性10年生存率为64.8%,无病10年生存率为28.6%。半数患者出现局部衰竭。未接受放疗的3例患者均出现局部衰竭。观察到双期复发模式。早期复发组的生存率明显低于晚期复发组。Hyams的组织病理学分级和颈部转移也与生存有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信